ANIMAL
STUDIES
a) completion of the 3 page CAMRIS approval form and
MR protocol page.
b) copy of the study protocol and/or IACUC application
form
c) copy of the IACUC approval letter
d)
For all animal studies a copy of the "Animal
Transport Letter" which allows transport of animals
within the University System (obtainable from Infection
Control Office 215-662-6995 )
e)
attach a list of the potential risks and the steps
to avoid them
For
tech supported Animal studies: To be scheduled after
all human scanning is done ( late afternoon/early
evening) to prevent collisions with human subjects.
Will be charged hourly rate scanner is in use.
For non-tech support Animal studies: must pay for
the first hour via a funded account or a PRODEV account
then subsequent hours of that same session can be
"no cost" (note: a new day is a new session)
To be done "after hours"
SPECIMEN
STUDIES
A) HUMAN
a) completion of the 3 page CAMRIS approval form and
MR protocol page
b) copy of the study protocol
c) copy of the "Claim of Exemption" from
the IRB
d) attach documentation for obtaining the specimens.
Note: If bringing in specimens from outside labs,
a letter from Infection Control is required. Specimens
coming from HUP's Pathology labs are considered "in-house"
and can be scanned as such.
B)
ANIMAL
a)
completion of the 3 page CAMRIS approval form and
MR protocol page
b) copy of the study protocol
c) copy of the regular animal form "A,"
as submitted to the IACUC, if as part of the protocol
they will be euthanizing and harvesting tissues/organs/and
body fluids from live animals.
d) or copy of the animal form "C,"as submitted
to the IACUC, For investigators who want to use animal
by-products ( fresh or frozen) obtained from other
investigators. The Investigators may use tissues or
individual organs of animals which were not exposed
to infectious agents or chemical contaminants.
e) copy of the IACUC approval letter
ADDITIONAL NOTES:
EXPERIMENTAL
COILS AND SOFTWARE must
be approved prior to usage on the Siemens systems.
For approval of experimental
coils and a serial number) contact Tom Connick
<
rfmail1@mail.mmrrcc.upenn.edu >
For pulse sequence and software approval contact Larry
Dougherty
< doughel@uphs.upenn.edu
>
IRB/CAMRIS
CONCURRENT APPLICATIONS from
Investigators may be submitted to CAMRIS for review
before their final submission to the IRB. Note: we
are now listed on the IRB's FACE SHEET. Upon receiving
a copy of the IRB approval letter and dated consent
form, a MRI billing account will then be set up for
your study. Note: all applications must be re-approved
annually.
DATA
ANALYSIS PLAN:
Describes the investigator's plan
to analyze the data such that a conclusion can be
drawn. Looking for no specific details, but a plan
for statistical analysis of the data to correlate
with the purpose of your study and/or experiment involving
human subjects. For small studies of limited risk,
a short description of your analysis plan is sufficient
while some of your more involved Drug studies may
have up to 10 pages.
MRI
BILLINGS
a) scan rates for government sponsored program grants
is $425.00 per hour.
b) scan rates for Clinical Trials (Pharmaceutical
Companies) is $575.00 per hour.
c) MRI IV contrast charges are $68.00 per 20 cc's
PRODEV
ACCOUNTS are for
10 one hour slots. To be used within one year of approval
date. If MRI contrast agents are to be used, PI must
provide a source of funding. NO CONTRAST AGENT IS
SUPPLIED FREE.
RADIOLOGY
REPORTS are not
provided as part of the Research Service. If you wish
to have a report generated, you must make your own
arrangements to have a Radiologist "on board"
who will be responsible for the interpretation and
dictation of a report.
CONTRAST
PRESCRIPTIONS:All
MR imaging protocols utilizing one of our in-stock
and pre-approved IV contrast agents must send a
prescription for the contrast for each subject being
scanned. The MD prescribing the contrast agent must
be the Investigator, a Co-Investigator or a Sub-Investigator.
Note: gadolinium-based IV contrast agents are not
approved in pregnant women and pregnant women must
be excluded from such trials.
|